×
0 0.00773195876288659 -0.0162714776632303 -0.0206185567010309 -0.0326460481099657 -0.0240549828178694 -0.0257731958762887 -0.0257731958762887
Stock impact report

BRIEF-Dermira Says Initiation Of First Phase 3 Clinical Study In Lebrikizumab Phase 3 Development Program Triggers A $7.5 Mln Milestone Payment By Almirall [Reuters]

Dermira, Inc (DERM)  More Company Research Source: Reuters
Last dermira, inc earnings: 8/7 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.dermira.com
PDF BRIEF-Dermira Says Initiation Of First Phase 3 Clinical Study In Lebrikizumab Phase 3 Development Program Triggers A $7.5 Mln Milestone Payment By Almirall - Reuters 1 Min Read Oct 9 (Reuters) - Dermira Inc: * DERMIRA - INITIATION OF FIRST PHASE 3 CLINICAL STUDY IN LEBRIKIZUMAB PHASE 3 DEVELOPMENT PROGRAM TRIGGERS A $7.5 MILLION MILESTONE PAYMENT BY ALMIRALL * DERMIRA - INITIATION OF LEBRIKIZUMAB PHASE 3 CLINICAL STUDY ALSO TRIGGERS A $20.0 MILLION MILESTONE PAYMENT BY DERMIRA TO F. HOFFMANN-LA ROCHE LTD Source text: ( bit.ly/2ICZUvg ) Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. Š 2019 Reuters. All Rights Reserved. BRIEF-Dermira Says Initiation Of First Phase 3 Clinical Study In Lebrikizumab Phase 3 Development Program Triggers A $7.5 Mln Milestone Payment By Almirall Oct 9 (Reuters) - Dermira Inc: * DERMIRA - INITIATION OF FIRST PHASE 3 CLINICAL STUDY IN LEBRIKIZUMAB PHASE 3 DEVELOPMENT PROGRAM [Read more]
Impact snapshot Event time: DERM
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
DERM alerts

from News Quantified
Opt-in for
DERM alerts

from News Quantified